Table 8.
Studies without the inclusion criteria.
| Reference | Molecule | CoQ10 mg/d |
Duration (d: Days) | Placebo | n Total/CoQ10 |
Type of Subjects | Sex | Sport/Activity | Exercise Testing | Age (Years) | Impact on Phys./Sport Perf | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Okudan et al. (2017) | [64] | Ubiquinone | 200 | 28 d | Yes | 21/11 | Non active | Male | - | Exccentric ex. | 23 ± 0 | No |
| Östman et al. (2012) | [65] | Ubiquinone | 90 | 56 d | Yes | 23/11 | Moderately trained subjects | Male | - | Various exercise capacity tests | 28 ± 9 | No |
| Porter et al. (1995) | [66] | Ubiquinone | 150 | 56 d | Yes | 13/6 | Physically active subjects | Male | Some with hypertension | Graded Max and Forearm Handgrip tests | 45 ± 2 | Yes |
| Snider et al. (1992) | [67] | Ubiquinone + | 100 + Vit E, C inosine, citochrome C | 28 d | Yes | 11/11 | High level | Male | Triathletes | Graded max. test | 25 ± 1 | No |
| Tauler et al. (2008) Ferrer et al. (2009) | [69,70] | Ubiquinone + | 100+ Multivitamin | 90 d | Yes | 19/8 | High level | Male | Soccer | Competition Match | 20 ± 0 | Yes |
| Vanfraechem et al. (1981) | [71] | Ubiquinone | 60 | 56 d | Yes | 6 | Non active | Male | None | Graded max. 4w–8w | 22 ± 2 | Yes |
| Wyss et al. (1990) | [73] | Ubiquinone | 100 | 30 d | Yes | 18/18 | Physically active subjects | Male | Running | Graded max. | 25 ± 4 | Yes |
| Yamabe et al. (1991) | [74] | Ubiquinone | 90 | 6 months | No | 9/9 | Non active with inabilities to do exercise | Male | - | Graded max. | 51 ± 5 | Yes |
| Ylikoski et al. (1997) | [75] | Ubiquinone | 90 | 42 d | Yes | 18/18 | High level | Male | cross-country skiers | Graded max. | Ns | Yes |
| Zeppilli et al. (1991) | [76] | Ubiquinone | 100 | 30 d | Yes | 9/9 | High level | Male | Volleyball | Graded max test | 17–2 | Yes |
| 10 | Non active | - | 23–29 | Yes | ||||||||
| 8 | Patients | Mit. Disease | 23–29 | Yes | ||||||||
| Zheng et al. (2008) | [77] | Ubiquinone | 30 | 1d | Yes | 11/11 | Non active | Male | - | Rest & Low intensity exercise (30% HRmax) | 26 ± 1 | Yes |
| Zhou et al. (2005) | [78] | Ubiquinone + | 150+ Vit E | 14 d | Yes | 6/6 | Physically active subjects | Male | - | Submaximal exercise and Graded max tests | 30 ± 7 | No |
| Zuliani et al. (1989) | [79] | Ubiquinone | 100 | 28 d | No | 12 | Non active | Male | - | 60’ ciloergometry | 26 | No |
| Sanchez-Cuesta et al. (2020) | [99] | . | - | 2 Sport seasons | - | 24 & 25 | High level | Male | Soccer | Weekly competition | 26 ± 4 | Yes |
+: indicates that the administration of Ubiquinone is supplemented by one or more other substances (indicated in the next column).